Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Asset Growth TrendStable
Percentile Rank57
5Y CAGR-16.5%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-16.5%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 17.13% |
| 2024 | 10.71% |
| 2023 | 7.99% |
| 2022 | -2.66% |
| 2021 | 6.93% |
| 2020 | 42.25% |
| 2019 | 52.09% |
| 2018 | -21.05% |
| 2017 | 57.96% |
| 2016 | -8.92% |